

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.49194347 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.97030364 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.97030364 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.57688415 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.50735993 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.43908152 |
| 7 | regulation of chronic inflammatory response (GO:0002676) | 5.09293281 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 5.05347139 |
| 9 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.97463170 |
| 10 | negative thymic T cell selection (GO:0045060) | 4.79032868 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.74485602 |
| 12 | negative T cell selection (GO:0043383) | 4.74437607 |
| 13 | NIK/NF-kappaB signaling (GO:0038061) | 4.71148514 |
| 14 | positive thymic T cell selection (GO:0045059) | 4.56304102 |
| 15 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.54010777 |
| 16 | positive regulation of B cell differentiation (GO:0045579) | 4.53040399 |
| 17 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.46062403 |
| 18 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.42769979 |
| 19 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.24122797 |
| 20 | response to interleukin-15 (GO:0070672) | 4.19561816 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.19145603 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 4.17836843 |
| 23 | regulation of B cell differentiation (GO:0045577) | 4.17709236 |
| 24 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.14000009 |
| 25 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.08407825 |
| 26 | ribosomal small subunit assembly (GO:0000028) | 3.96812390 |
| 27 | regulation of vitamin metabolic process (GO:0030656) | 3.85593339 |
| 28 | regulation of immunoglobulin secretion (GO:0051023) | 3.85369444 |
| 29 | T cell migration (GO:0072678) | 3.85328078 |
| 30 | leukocyte aggregation (GO:0070486) | 3.84780936 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 3.82326254 |
| 32 | regulation of interferon-alpha production (GO:0032647) | 3.82210812 |
| 33 | thymic T cell selection (GO:0045061) | 3.81989774 |
| 34 | T cell homeostasis (GO:0043029) | 3.74554413 |
| 35 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.72556099 |
| 36 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.70845161 |
| 37 | positive T cell selection (GO:0043368) | 3.68641881 |
| 38 | interferon-gamma production (GO:0032609) | 3.68251940 |
| 39 | regulation of regulatory T cell differentiation (GO:0045589) | 3.67931367 |
| 40 | myeloid dendritic cell activation (GO:0001773) | 3.66282723 |
| 41 | positive regulation of isotype switching (GO:0045830) | 3.65802492 |
| 42 | activation of MAPKKK activity (GO:0000185) | 3.65436982 |
| 43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.62181799 |
| 44 | negative regulation of cell killing (GO:0031342) | 3.62181799 |
| 45 | response to peptidoglycan (GO:0032494) | 3.61330045 |
| 46 | B cell receptor signaling pathway (GO:0050853) | 3.54947668 |
| 47 | viral transcription (GO:0019083) | 3.53703294 |
| 48 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.52299045 |
| 49 | T cell selection (GO:0045058) | 3.51016090 |
| 50 | myeloid dendritic cell differentiation (GO:0043011) | 3.50608046 |
| 51 | T-helper 1 type immune response (GO:0042088) | 3.47981641 |
| 52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.43221260 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.42042515 |
| 54 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.41472914 |
| 55 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.40754469 |
| 56 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.40494121 |
| 57 | positive regulation of interferon-alpha production (GO:0032727) | 3.38861004 |
| 58 | immunoglobulin mediated immune response (GO:0016064) | 3.38841204 |
| 59 | translational termination (GO:0006415) | 3.38380347 |
| 60 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.38025124 |
| 61 | mature B cell differentiation (GO:0002335) | 3.37926843 |
| 62 | positive regulation of heat generation (GO:0031652) | 3.37742817 |
| 63 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.34736531 |
| 64 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.33827342 |
| 65 | regulation of fever generation (GO:0031620) | 3.32412569 |
| 66 | T cell receptor signaling pathway (GO:0050852) | 3.32007718 |
| 67 | defense response to protozoan (GO:0042832) | 3.31958289 |
| 68 | T cell lineage commitment (GO:0002360) | 3.31323797 |
| 69 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.30800283 |
| 70 | response to protozoan (GO:0001562) | 3.29855930 |
| 71 | regulation of interleukin-12 production (GO:0032655) | 3.29840620 |
| 72 | regulation of podosome assembly (GO:0071801) | 3.28921238 |
| 73 | positive regulation of humoral immune response (GO:0002922) | 3.27191918 |
| 74 | response to type I interferon (GO:0034340) | 3.24946562 |
| 75 | positive regulation of B cell mediated immunity (GO:0002714) | 3.23261693 |
| 76 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.23261693 |
| 77 | type I interferon signaling pathway (GO:0060337) | 3.22463150 |
| 78 | cellular response to type I interferon (GO:0071357) | 3.22463150 |
| 79 | lymphocyte homeostasis (GO:0002260) | 3.21872925 |
| 80 | mast cell activation (GO:0045576) | 3.20797802 |
| 81 | positive regulation by symbiont of host defense response (GO:0052509) | 3.20753951 |
| 82 | modulation by symbiont of host defense response (GO:0052031) | 3.20753951 |
| 83 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.20753951 |
| 84 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.20753951 |
| 85 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.20753951 |
| 86 | modulation by symbiont of host immune response (GO:0052553) | 3.20753951 |
| 87 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.19556923 |
| 88 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.17708336 |
| 89 | cellular response to interferon-gamma (GO:0071346) | 3.17693363 |
| 90 | regulation of chemokine biosynthetic process (GO:0045073) | 3.17538977 |
| 91 | dendritic cell differentiation (GO:0097028) | 3.16689238 |
| 92 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.16009535 |
| 93 | T cell costimulation (GO:0031295) | 3.15589625 |
| 94 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.14780930 |
| 95 | negative regulation of viral genome replication (GO:0045071) | 3.14359622 |
| 96 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.14241551 |
| 97 | tolerance induction (GO:0002507) | 3.13540177 |
| 98 | positive regulation of interleukin-2 production (GO:0032743) | 3.13050427 |
| 99 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.12205593 |
| 100 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.11872543 |
| 101 | lymphocyte costimulation (GO:0031294) | 3.11636615 |
| 102 | positive regulation of DNA recombination (GO:0045911) | 3.11414719 |
| 103 | regulation of T-helper cell differentiation (GO:0045622) | 3.11318854 |
| 104 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.11243330 |
| 105 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.09882180 |
| 106 | regulation of response to interferon-gamma (GO:0060330) | 3.09785313 |
| 107 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.08100339 |
| 108 | positive regulation of interleukin-12 production (GO:0032735) | 3.07754986 |
| 109 | regulation of B cell mediated immunity (GO:0002712) | 3.06753787 |
| 110 | positive regulation of B cell proliferation (GO:0030890) | 3.06709158 |
| 111 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.06059294 |
| 112 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.05887727 |
| 113 | regulation of necroptotic process (GO:0060544) | 3.04771038 |
| 114 | regulation of isotype switching (GO:0045191) | 3.04750593 |
| 115 | Peyers patch development (GO:0048541) | 3.04298923 |
| 116 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.04298923 |
| 117 | mature B cell differentiation involved in immune response (GO:0002313) | 3.04247422 |
| 118 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.03283131 |
| 119 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.03281641 |
| 120 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.03145023 |
| 121 | leukocyte homeostasis (GO:0001776) | 3.01816716 |
| 122 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.01469571 |
| 123 | definitive hemopoiesis (GO:0060216) | 3.01221394 |
| 124 | macrophage activation involved in immune response (GO:0002281) | 3.00367129 |
| 125 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.00288079 |
| 126 | positive regulation of interferon-gamma production (GO:0032729) | 2.99635610 |
| 127 | positive regulation of type 2 immune response (GO:0002830) | 2.99459572 |
| 128 | positive regulation of interleukin-10 production (GO:0032733) | 2.98822318 |
| 129 | regulation of interleukin-2 production (GO:0032663) | 2.96802887 |
| 130 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.95248467 |
| 131 | lymph node development (GO:0048535) | 2.94941683 |
| 132 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.92890023 |
| 133 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.92539957 |
| 134 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.92539957 |
| 135 | ribosomal small subunit biogenesis (GO:0042274) | 2.91463815 |
| 136 | translational elongation (GO:0006414) | 2.91127918 |
| 137 | T cell differentiation (GO:0030217) | 2.89452999 |
| 138 | response to muramyl dipeptide (GO:0032495) | 2.89428839 |
| 139 | natural killer cell activation (GO:0030101) | 2.88530030 |
| 140 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.87731849 |
| 141 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.87731849 |
| 142 | B cell mediated immunity (GO:0019724) | 2.86388539 |
| 143 | megakaryocyte development (GO:0035855) | 2.85998818 |
| 144 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.82538704 |
| 145 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.76424402 |
| 146 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.76057348 |
| 147 | germinal center formation (GO:0002467) | 2.75928533 |
| 148 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.75499886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.96039087 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.41243166 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.22090310 |
| 4 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.12114621 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.69136942 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.53664031 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.42590078 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.20558878 |
| 9 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.01077292 |
| 10 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.89805887 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.81904729 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.77138942 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.73250096 |
| 14 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.73105043 |
| 15 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65051401 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.64659176 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.63312431 |
| 18 | * MAF_26560356_Chip-Seq_TH1_Human | 2.59127283 |
| 19 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.58417118 |
| 20 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.52000335 |
| 21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.45758060 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.44581972 |
| 23 | * MYB_26560356_Chip-Seq_TH1_Human | 2.31861236 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.31389530 |
| 25 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.21245189 |
| 26 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20506268 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.20257784 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15325215 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12227017 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.10966247 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10846486 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.08416666 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06805431 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03755784 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02396445 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00901973 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98113081 |
| 38 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97725013 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96703509 |
| 40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.88967488 |
| 41 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84349757 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73437120 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.70202824 |
| 44 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69207079 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68707452 |
| 46 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.67487615 |
| 47 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61621616 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60889575 |
| 49 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.55682364 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54458279 |
| 51 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.52324424 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52278223 |
| 53 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48515632 |
| 54 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.46604581 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45739451 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44975598 |
| 57 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43482542 |
| 58 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.42560167 |
| 59 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.42423407 |
| 60 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40016708 |
| 61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37899371 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36290373 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36211785 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36074672 |
| 65 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35715584 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34582654 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34289868 |
| 68 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31699947 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30265682 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29161778 |
| 71 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26086406 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22382238 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20724780 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.20095917 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16046185 |
| 76 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.13665121 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11574144 |
| 78 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09274947 |
| 79 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.08683565 |
| 80 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08087801 |
| 81 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.06593149 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06131727 |
| 83 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.05949811 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05426505 |
| 85 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02660982 |
| 86 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.01959743 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01551072 |
| 88 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.01492399 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00924513 |
| 90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00635823 |
| 91 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.00581504 |
| 92 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00103083 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00073669 |
| 94 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.97466858 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96735193 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96310450 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95592491 |
| 98 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.94080113 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91731327 |
| 100 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89841606 |
| 101 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88383786 |
| 102 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88363889 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87913884 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87766607 |
| 105 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86642420 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86094285 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85350418 |
| 108 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.84548583 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84431653 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84320543 |
| 111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83839495 |
| 112 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.83627514 |
| 113 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82853391 |
| 114 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.82470636 |
| 115 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81759497 |
| 116 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.81273952 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79770004 |
| 118 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79526799 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78966224 |
| 120 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78909435 |
| 121 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.78876176 |
| 122 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78543075 |
| 123 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.77977408 |
| 124 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76627230 |
| 125 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75508551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.08379751 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.01931647 |
| 3 | MP0005671_abnormal_response_to | 3.99197093 |
| 4 | MP0000685_abnormal_immune_system | 3.79586253 |
| 5 | MP0001800_abnormal_humoral_immune | 3.31129942 |
| 6 | MP0002396_abnormal_hematopoietic_system | 3.09300721 |
| 7 | MP0009785_altered_susceptibility_to | 3.02962592 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.90715239 |
| 9 | MP0005387_immune_system_phenotype | 2.88484904 |
| 10 | MP0001790_abnormal_immune_system | 2.88484904 |
| 11 | * MP0005000_abnormal_immune_tolerance | 2.86141033 |
| 12 | MP0002398_abnormal_bone_marrow | 2.80970892 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.77926054 |
| 14 | * MP0002723_abnormal_immune_serum | 2.77595206 |
| 15 | * MP0002420_abnormal_adaptive_immunity | 2.76010557 |
| 16 | * MP0001819_abnormal_immune_cell | 2.71942046 |
| 17 | MP0005025_abnormal_response_to | 2.55216297 |
| 18 | * MP0003436_decreased_susceptibility_to | 2.49838665 |
| 19 | MP0000716_abnormal_immune_system | 2.41839011 |
| 20 | MP0001853_heart_inflammation | 2.32254385 |
| 21 | MP0000689_abnormal_spleen_morphology | 2.30531832 |
| 22 | MP0002405_respiratory_system_inflammati | 2.28154327 |
| 23 | MP0002006_tumorigenesis | 2.25290327 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 2.23617013 |
| 25 | MP0002722_abnormal_immune_system | 2.22729407 |
| 26 | MP0001873_stomach_inflammation | 2.20627295 |
| 27 | MP0000703_abnormal_thymus_morphology | 2.16617233 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 2.15602610 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.13935653 |
| 30 | MP0003303_peritoneal_inflammation | 2.11189247 |
| 31 | MP0003724_increased_susceptibility_to | 2.10239012 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 2.10073586 |
| 33 | MP0003866_abnormal_defecation | 2.07280354 |
| 34 | MP0002429_abnormal_blood_cell | 2.06608791 |
| 35 | MP0003300_gastrointestinal_ulcer | 2.06535379 |
| 36 | MP0004510_myositis | 2.05762774 |
| 37 | * MP0002419_abnormal_innate_immunity | 2.03774514 |
| 38 | MP0005464_abnormal_platelet_physiology | 2.00226359 |
| 39 | MP0005451_abnormal_body_composition | 1.94329011 |
| 40 | MP0004947_skin_inflammation | 1.90199272 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.79019679 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.79019679 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.76864042 |
| 44 | MP0002933_joint_inflammation | 1.69509963 |
| 45 | MP0006082_CNS_inflammation | 1.68023705 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.62932019 |
| 47 | MP0008057_abnormal_DNA_replication | 1.54193298 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.53540870 |
| 49 | MP0000490_abnormal_crypts_of | 1.51960619 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.41914298 |
| 51 | MP0009278_abnormal_bone_marrow | 1.37377598 |
| 52 | MP0005058_abnormal_lysosome_morphology | 1.37110432 |
| 53 | MP0002139_abnormal_hepatobiliary_system | 1.32425240 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.26305394 |
| 55 | MP0003075_altered_response_to | 1.24233030 |
| 56 | MP0008469_abnormal_protein_level | 1.19959504 |
| 57 | MP0000858_altered_metastatic_potential | 1.19689402 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.18449468 |
| 59 | MP0009840_abnormal_foam_cell | 1.17938206 |
| 60 | MP0005310_abnormal_salivary_gland | 1.17444489 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 1.09665776 |
| 62 | MP0008007_abnormal_cellular_replicative | 1.08959191 |
| 63 | MP0008004_abnormal_stomach_pH | 1.08726364 |
| 64 | MP0002095_abnormal_skin_pigmentation | 1.05651397 |
| 65 | MP0002332_abnormal_exercise_endurance | 1.03922297 |
| 66 | MP0005166_decreased_susceptibility_to | 1.00714942 |
| 67 | MP0003077_abnormal_cell_cycle | 0.99774782 |
| 68 | MP0010094_abnormal_chromosome_stability | 0.99247611 |
| 69 | * MP0001533_abnormal_skeleton_physiology | 0.98748915 |
| 70 | MP0002132_abnormal_respiratory_system | 0.97441418 |
| 71 | MP0003448_altered_tumor_morphology | 0.97264195 |
| 72 | MP0000015_abnormal_ear_pigmentation | 0.93606400 |
| 73 | MP0001851_eye_inflammation | 0.93153736 |
| 74 | MP0000604_amyloidosis | 0.91308224 |
| 75 | MP0003693_abnormal_embryo_hatching | 0.88885619 |
| 76 | MP0003091_abnormal_cell_migration | 0.81858924 |
| 77 | MP0002009_preneoplasia | 0.80279681 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.79921368 |
| 79 | MP0003045_fibrosis | 0.77887931 |
| 80 | MP0008058_abnormal_DNA_repair | 0.77549803 |
| 81 | MP0006054_spinal_hemorrhage | 0.75489013 |
| 82 | MP0001501_abnormal_sleep_pattern | 0.74698832 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.73253088 |
| 84 | MP0005076_abnormal_cell_differentiation | 0.70914181 |
| 85 | MP0004957_abnormal_blastocyst_morpholog | 0.70696408 |
| 86 | MP0000313_abnormal_cell_death | 0.70080762 |
| 87 | MP0001348_abnormal_lacrimal_gland | 0.68832777 |
| 88 | MP0009764_decreased_sensitivity_to | 0.68149451 |
| 89 | MP0003943_abnormal_hepatobiliary_system | 0.67748303 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.65582550 |
| 91 | MP0009763_increased_sensitivity_to | 0.65093383 |
| 92 | MP0002163_abnormal_gland_morphology | 0.64220479 |
| 93 | MP0003828_pulmonary_edema | 0.63976434 |
| 94 | MP0004381_abnormal_hair_follicle | 0.63960862 |
| 95 | MP0001663_abnormal_digestive_system | 0.63458453 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.62327505 |
| 97 | MP0005165_increased_susceptibility_to | 0.61370590 |
| 98 | * MP0005390_skeleton_phenotype | 0.60926054 |
| 99 | MP0008874_decreased_physiological_sensi | 0.60451928 |
| 100 | MP0001542_abnormal_bone_strength | 0.60346262 |
| 101 | MP0001727_abnormal_embryo_implantation | 0.59199651 |
| 102 | MP0000609_abnormal_liver_physiology | 0.58199430 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.58181365 |
| 104 | MP0000371_diluted_coat_color | 0.57783531 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.57754933 |
| 106 | MP0005023_abnormal_wound_healing | 0.56296510 |
| 107 | MP0000477_abnormal_intestine_morphology | 0.55554862 |
| 108 | MP0005647_abnormal_sex_gland | 0.55454949 |
| 109 | MP0000249_abnormal_blood_vessel | 0.55423855 |
| 110 | MP0000350_abnormal_cell_proliferation | 0.52962362 |
| 111 | MP0005535_abnormal_body_temperature | 0.52929920 |
| 112 | MP0003453_abnormal_keratinocyte_physiol | 0.52457505 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 0.52007470 |
| 114 | MP0001879_abnormal_lymphatic_vessel | 0.51280163 |
| 115 | MP0008260_abnormal_autophagy | 0.50985372 |
| 116 | MP0002928_abnormal_bile_duct | 0.50507123 |
| 117 | MP0003111_abnormal_nucleus_morphology | 0.50295885 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.48727417 |
| 119 | MP0001919_abnormal_reproductive_system | 0.48174723 |
| 120 | MP0001191_abnormal_skin_condition | 0.47915123 |
| 121 | MP0010307_abnormal_tumor_latency | 0.46794217 |
| 122 | MP0003656_abnormal_erythrocyte_physiolo | 0.45223008 |
| 123 | MP0000598_abnormal_liver_morphology | 0.44963862 |
| 124 | MP0003795_abnormal_bone_structure | 0.44502337 |
| 125 | MP0000343_altered_response_to | 0.43917595 |
| 126 | MP0002254_reproductive_system_inflammat | 0.43052759 |
| 127 | MP0003183_abnormal_peptide_metabolism | 0.42843789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.95088881 |
| 2 | Chronic otitis media (HP:0000389) | 4.84395917 |
| 3 | Recurrent bronchitis (HP:0002837) | 4.68811477 |
| 4 | Panhypogammaglobulinemia (HP:0003139) | 4.62278673 |
| 5 | Thrombocytosis (HP:0001894) | 4.54903393 |
| 6 | Stomatitis (HP:0010280) | 4.47561203 |
| 7 | IgM deficiency (HP:0002850) | 4.46069921 |
| 8 | Abnormality of B cell number (HP:0010975) | 4.35197376 |
| 9 | B lymphocytopenia (HP:0010976) | 4.35197376 |
| 10 | T lymphocytopenia (HP:0005403) | 4.32176491 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.20719400 |
| 12 | Abnormality of T cell number (HP:0011839) | 4.16255310 |
| 13 | Recurrent viral infections (HP:0004429) | 4.11169227 |
| 14 | Abnormality of T cells (HP:0002843) | 4.06706048 |
| 15 | Severe combined immunodeficiency (HP:0004430) | 4.03504358 |
| 16 | IgG deficiency (HP:0004315) | 4.02047806 |
| 17 | Myositis (HP:0100614) | 3.99437845 |
| 18 | Nasal polyposis (HP:0100582) | 3.93394317 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.89150074 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.86830374 |
| 21 | Autoimmune hemolytic anemia (HP:0001890) | 3.78245504 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.76985208 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 3.69563351 |
| 24 | Abnormality of the nasal mucosa (HP:0000433) | 3.66866191 |
| 25 | Recurrent abscess formation (HP:0002722) | 3.60016054 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.59338327 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.59338327 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 3.55759348 |
| 29 | Combined immunodeficiency (HP:0005387) | 3.55207975 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.47950307 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.47950307 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 3.47950307 |
| 33 | Lymphopenia (HP:0001888) | 3.44096518 |
| 34 | Keratoconjunctivitis (HP:0001096) | 3.42801487 |
| 35 | Aplastic anemia (HP:0001915) | 3.36200810 |
| 36 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.32630629 |
| 37 | Meningitis (HP:0001287) | 3.29818322 |
| 38 | Thyroiditis (HP:0100646) | 3.29730155 |
| 39 | Inflammation of the large intestine (HP:0002037) | 3.27293770 |
| 40 | Gastrointestinal inflammation (HP:0004386) | 3.22950618 |
| 41 | Vasculitis (HP:0002633) | 3.22297094 |
| 42 | Recurrent bacterial skin infections (HP:0005406) | 3.12898010 |
| 43 | Gastrointestinal stroma tumor (HP:0100723) | 3.12830139 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 3.09801990 |
| 45 | Gangrene (HP:0100758) | 3.09039432 |
| 46 | Colitis (HP:0002583) | 3.04490327 |
| 47 | Chronic diarrhea (HP:0002028) | 3.04121882 |
| 48 | Lymphoma (HP:0002665) | 3.02628779 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.92421727 |
| 50 | Recurrent skin infections (HP:0001581) | 2.91013821 |
| 51 | Cellulitis (HP:0100658) | 2.85869959 |
| 52 | Fatigue (HP:0012378) | 2.83426886 |
| 53 | Recurrent sinusitis (HP:0011108) | 2.81723375 |
| 54 | Leukocytosis (HP:0001974) | 2.80794424 |
| 55 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.79261038 |
| 56 | Reticulocytopenia (HP:0001896) | 2.78118966 |
| 57 | Abnormality of eosinophils (HP:0001879) | 2.77479529 |
| 58 | Amaurosis fugax (HP:0100576) | 2.76104218 |
| 59 | Abnormality of the fingertips (HP:0001211) | 2.75352599 |
| 60 | Chronic sinusitis (HP:0011109) | 2.72239021 |
| 61 | Abnormal number of erythroid precursors (HP:0012131) | 2.70853415 |
| 62 | Increased IgE level (HP:0003212) | 2.70601939 |
| 63 | Epistaxis (HP:0000421) | 2.68768338 |
| 64 | Restrictive lung disease (HP:0002091) | 2.68499433 |
| 65 | Increased IgM level (HP:0003496) | 2.68110680 |
| 66 | Bronchitis (HP:0012387) | 2.65167949 |
| 67 | Chest pain (HP:0100749) | 2.64411102 |
| 68 | Arterial thrombosis (HP:0004420) | 2.64246296 |
| 69 | Prolonged bleeding time (HP:0003010) | 2.64102855 |
| 70 | Abnormality of the pleura (HP:0002103) | 2.62963362 |
| 71 | Pustule (HP:0200039) | 2.62283137 |
| 72 | Retrobulbar optic neuritis (HP:0100654) | 2.62261617 |
| 73 | Optic neuritis (HP:0100653) | 2.62261617 |
| 74 | Hypoplasia of the thymus (HP:0000778) | 2.62163473 |
| 75 | IgA deficiency (HP:0002720) | 2.61868693 |
| 76 | Acute myeloid leukemia (HP:0004808) | 2.60120446 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.59846960 |
| 78 | Petechiae (HP:0000967) | 2.57687229 |
| 79 | Pulmonary infiltrates (HP:0002113) | 2.54807936 |
| 80 | Vacuolated lymphocytes (HP:0001922) | 2.51158993 |
| 81 | Urticaria (HP:0001025) | 2.49540458 |
| 82 | Abnormal platelet function (HP:0011869) | 2.49103449 |
| 83 | Impaired platelet aggregation (HP:0003540) | 2.49103449 |
| 84 | Orchitis (HP:0100796) | 2.48252581 |
| 85 | Arthralgia (HP:0002829) | 2.46435961 |
| 86 | Dysostosis multiplex (HP:0000943) | 2.45456282 |
| 87 | Emphysema (HP:0002097) | 2.45155602 |
| 88 | Hemoptysis (HP:0002105) | 2.45061489 |
| 89 | Gastrointestinal infarctions (HP:0005244) | 2.42215511 |
| 90 | Loss of speech (HP:0002371) | 2.40970440 |
| 91 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40669712 |
| 92 | Obstructive lung disease (HP:0006536) | 2.40669712 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39952599 |
| 94 | Eosinophilia (HP:0001880) | 2.39895439 |
| 95 | Poikiloderma (HP:0001029) | 2.36775905 |
| 96 | Granulocytopenia (HP:0001913) | 2.35474376 |
| 97 | Encephalitis (HP:0002383) | 2.35362319 |
| 98 | Polyneuropathy (HP:0001271) | 2.34002735 |
| 99 | Systemic lupus erythematosus (HP:0002725) | 2.32806649 |
| 100 | Interstitial pulmonary disease (HP:0006530) | 2.27153615 |
| 101 | Anorexia (HP:0002039) | 2.26843860 |
| 102 | Gingival bleeding (HP:0000225) | 2.26172198 |
| 103 | Papilloma (HP:0012740) | 2.24806307 |
| 104 | Verrucae (HP:0200043) | 2.24806307 |
| 105 | Abnormality of macrophages (HP:0004311) | 2.23994971 |
| 106 | Pallor (HP:0000980) | 2.23487373 |
| 107 | Microcytic anemia (HP:0001935) | 2.22592704 |
| 108 | Pulmonary embolism (HP:0002204) | 2.19228724 |
| 109 | Parakeratosis (HP:0001036) | 2.19223281 |
| 110 | Recurrent lower respiratory tract infections (HP:0002783) | 2.18435700 |
| 111 | Recurrent pneumonia (HP:0006532) | 2.17751428 |
| 112 | Keratitis (HP:0000491) | 2.17646285 |
| 113 | Glomerulopathy (HP:0100820) | 2.17441256 |
| 114 | Neutropenia (HP:0001875) | 2.17218851 |
| 115 | Increased serum ferritin (HP:0003281) | 2.15796441 |
| 116 | Hypertensive crisis (HP:0100735) | 2.15444642 |
| 117 | Autoimmune thrombocytopenia (HP:0001973) | 2.14414785 |
| 118 | Hematochezia (HP:0002573) | 2.12091649 |
| 119 | Acute hepatic failure (HP:0006554) | 2.11257038 |
| 120 | Abnormality of the prostate (HP:0008775) | 2.08672849 |
| 121 | Increased density of long bones (HP:0006392) | 2.03064247 |
| 122 | Increased cerebral lipofuscin (HP:0011813) | 2.02824277 |
| 123 | Hypoproteinemia (HP:0003075) | 2.02058331 |
| 124 | Osteomyelitis (HP:0002754) | 2.01530371 |
| 125 | Pancytopenia (HP:0001876) | 2.00408200 |
| 126 | Albinism (HP:0001022) | 2.00049144 |
| 127 | Joint swelling (HP:0001386) | 1.96913467 |
| 128 | Basal cell carcinoma (HP:0002671) | 1.96350692 |
| 129 | Basal ganglia calcification (HP:0002135) | 1.93119856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.45787705 |
| 2 | TXK | 3.79790455 |
| 3 | PRPF4B | 3.61609233 |
| 4 | JAK3 | 3.12455614 |
| 5 | ZAP70 | 2.83943534 |
| 6 | MAP3K14 | 2.69482388 |
| 7 | TYK2 | 2.43042595 |
| 8 | KIT | 2.39356908 |
| 9 | TBK1 | 2.39324519 |
| 10 | IKBKE | 2.37647403 |
| 11 | EEF2K | 2.26570333 |
| 12 | MAP3K10 | 2.24390874 |
| 13 | PIM2 | 2.16420004 |
| 14 | BMPR2 | 2.10714791 |
| 15 | ITK | 2.05325848 |
| 16 | BTK | 2.04285738 |
| 17 | TEC | 2.03868946 |
| 18 | IKBKB | 1.98202743 |
| 19 | KDR | 1.84856524 |
| 20 | NLK | 1.82410445 |
| 21 | IRAK4 | 1.73635924 |
| 22 | SYK | 1.72394985 |
| 23 | NME2 | 1.71245836 |
| 24 | CSF1R | 1.64027715 |
| 25 | FGFR4 | 1.62231371 |
| 26 | LCK | 1.61760077 |
| 27 | GRK6 | 1.61314195 |
| 28 | GRK7 | 1.59508419 |
| 29 | STK10 | 1.46731402 |
| 30 | FLT3 | 1.40053498 |
| 31 | JAK1 | 1.39034031 |
| 32 | MAP2K3 | 1.38654090 |
| 33 | BLK | 1.28721724 |
| 34 | CHUK | 1.27100142 |
| 35 | FES | 1.24371764 |
| 36 | PIM1 | 1.24211605 |
| 37 | MAP3K13 | 1.23601019 |
| 38 | DDR2 | 1.21315770 |
| 39 | TGFBR1 | 1.20731753 |
| 40 | HCK | 1.20240244 |
| 41 | TAOK3 | 1.19200513 |
| 42 | LRRK2 | 1.17923178 |
| 43 | RPS6KA4 | 1.17383764 |
| 44 | FGFR3 | 1.16179588 |
| 45 | TGFBR2 | 1.11593444 |
| 46 | CSK | 1.11471005 |
| 47 | LYN | 1.04798047 |
| 48 | MAP3K11 | 1.03641681 |
| 49 | DYRK3 | 0.96994341 |
| 50 | TESK2 | 0.95805415 |
| 51 | FGR | 0.95281793 |
| 52 | SMG1 | 0.91698684 |
| 53 | NEK9 | 0.90952139 |
| 54 | MOS | 0.88776579 |
| 55 | IRAK2 | 0.87708027 |
| 56 | RIPK1 | 0.86942841 |
| 57 | IRAK3 | 0.85110389 |
| 58 | RPS6KB2 | 0.84766508 |
| 59 | CDC42BPA | 0.82836409 |
| 60 | RAF1 | 0.78806010 |
| 61 | EPHB1 | 0.77432654 |
| 62 | TSSK6 | 0.77391585 |
| 63 | SIK3 | 0.77135694 |
| 64 | CLK1 | 0.77055041 |
| 65 | MAPK7 | 0.74569060 |
| 66 | MAP3K1 | 0.70661697 |
| 67 | MAP3K5 | 0.70191292 |
| 68 | TLK1 | 0.68830279 |
| 69 | SIK2 | 0.68089329 |
| 70 | EIF2AK3 | 0.67834646 |
| 71 | TYRO3 | 0.67502355 |
| 72 | JAK2 | 0.65160560 |
| 73 | TRIB3 | 0.63817734 |
| 74 | RIPK4 | 0.63748090 |
| 75 | HIPK2 | 0.63198157 |
| 76 | ERN1 | 0.62812493 |
| 77 | MAP3K7 | 0.62463553 |
| 78 | MAPK4 | 0.61807765 |
| 79 | TAOK1 | 0.60850296 |
| 80 | CDK12 | 0.60296218 |
| 81 | EPHA3 | 0.59289099 |
| 82 | BRD4 | 0.59164093 |
| 83 | PKN2 | 0.58549827 |
| 84 | PRKCQ | 0.56210208 |
| 85 | MAP3K12 | 0.55240819 |
| 86 | NEK2 | 0.53747907 |
| 87 | RPS6KA5 | 0.53187554 |
| 88 | CDK19 | 0.51834060 |
| 89 | TNK2 | 0.51603554 |
| 90 | MAPKAPK3 | 0.51513324 |
| 91 | IRAK1 | 0.51276710 |
| 92 | TAOK2 | 0.49878711 |
| 93 | CDK4 | 0.48200718 |
| 94 | STK24 | 0.46583860 |
| 95 | MAP2K2 | 0.44742125 |
| 96 | MAP3K3 | 0.44613069 |
| 97 | VRK1 | 0.44324855 |
| 98 | PASK | 0.43720952 |
| 99 | SIK1 | 0.43668619 |
| 100 | WEE1 | 0.43638742 |
| 101 | MAP3K8 | 0.43635435 |
| 102 | CAMKK1 | 0.43606850 |
| 103 | MATK | 0.43604380 |
| 104 | CDK9 | 0.43263201 |
| 105 | DAPK3 | 0.41953730 |
| 106 | TNIK | 0.41625159 |
| 107 | EIF2AK2 | 0.40670345 |
| 108 | MARK3 | 0.40106406 |
| 109 | ADRBK2 | 0.38808952 |
| 110 | PRKCH | 0.38261735 |
| 111 | MAPKAPK2 | 0.38126431 |
| 112 | INSR | 0.36642105 |
| 113 | MST4 | 0.36505502 |
| 114 | PKN1 | 0.35819053 |
| 115 | ABL1 | 0.34840734 |
| 116 | ACVR1B | 0.34607687 |
| 117 | TIE1 | 0.33741241 |
| 118 | ARAF | 0.31860681 |
| 119 | CDC7 | 0.31520227 |
| 120 | ALK | 0.31476202 |
| 121 | RPS6KA6 | 0.31448644 |
| 122 | SCYL2 | 0.31369892 |
| 123 | MELK | 0.31012745 |
| 124 | RPS6KC1 | 0.30574727 |
| 125 | RPS6KL1 | 0.30574727 |
| 126 | ATR | 0.29973998 |
| 127 | MAPK11 | 0.29188488 |
| 128 | MAPK12 | 0.28763551 |
| 129 | MAPK3 | 0.28412564 |
| 130 | STK4 | 0.27777926 |
| 131 | PDK2 | 0.27700641 |
| 132 | PDK1 | 0.27182173 |
| 133 | MARK2 | 0.26552059 |
| 134 | RPS6KA1 | 0.24134447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.28968478 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.91221399 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.53279198 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.51143767 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.50377641 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.50138113 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.48961502 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.44279505 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41107830 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.40430785 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 2.37064694 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.26212585 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09353299 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.09339334 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.03161295 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98666801 |
| 17 | DNA replication_Homo sapiens_hsa03030 | 1.91885872 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87435237 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.85739819 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.71970543 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56255834 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54643148 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54553325 |
| 24 | Base excision repair_Homo sapiens_hsa03410 | 1.47767173 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.44912854 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44004203 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.42530961 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42257337 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.40699206 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.36535925 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.35721760 |
| 32 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.29804234 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.28404805 |
| 34 | Spliceosome_Homo sapiens_hsa03040 | 1.27791182 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.25906727 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.25351191 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25148954 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.25129028 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23680260 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.23259233 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20165324 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12533567 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09917573 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.09151644 |
| 45 | HTLV-I infection_Homo sapiens_hsa05166 | 1.08350340 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.08218944 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08127743 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07940106 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 1.00655059 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96559456 |
| 51 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.96539480 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94420655 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.89789963 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88705131 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85037656 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.84601695 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 0.84497725 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80989148 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80088642 |
| 60 | Homologous recombination_Homo sapiens_hsa03440 | 0.78298353 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.78191805 |
| 62 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.75919896 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75880607 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75846065 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74484190 |
| 66 | RNA degradation_Homo sapiens_hsa03018 | 0.73585352 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72742267 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70782306 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.65850264 |
| 70 | Proteasome_Homo sapiens_hsa03050 | 0.64934905 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64732658 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64181360 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63655887 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.63322259 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63210045 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 0.61174392 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60735591 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60558670 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.56587743 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56518061 |
| 81 | Cell cycle_Homo sapiens_hsa04110 | 0.53996743 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53731027 |
| 83 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.52770187 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51004056 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49984985 |
| 86 | RNA transport_Homo sapiens_hsa03013 | 0.48222181 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46334679 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45127467 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43859494 |
| 90 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41768342 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41228145 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40764337 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40509545 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.36185876 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34002021 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33639980 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33290237 |
| 98 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32688805 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.30860516 |
| 100 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.28734890 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28362463 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.26671238 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26495418 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.25741200 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24670786 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.24566393 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24409548 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24031036 |
| 109 | Alcoholism_Homo sapiens_hsa05034 | 0.23052975 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.23012601 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.21397885 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20964986 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.20631829 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.16848918 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.12348077 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.11509163 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.10430603 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.09024843 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.07959390 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.07605331 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.07194196 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01745342 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.01159498 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0517283 |

